Skip to content

Author

H. Jang

We have 6 of 251 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

From static structures to dynamic energy landscapes: the latest revolution in molecular biology.

Over a decade ago, in an Editorial, we proposed that beyond the foundational discovery of the DNA double helix, modern molecular biology has undergone a second revolution: a shift from static, single-structure models to dynamic, ensemble-based energy landscapes that define biomolecular function. Recently, Quarterly Rev...

R. Nussinov, H. Jang, P. Wolynes · 0 citations
Review Open access Aug 2026

Kinase cascades: emerging design principles and guidelines

It is proposed that the order of kinases in cascades is dictated by their conformational character, a mechanism amplified in cascade-enriched biomolecular condensates—establishing design principles for pathway-selective, cascade-directed therapeutics.

R. Nussinov, Clil Regev, H. Jang · 0 citations
Review Open access Sep 2026

Molecular Glue Degraders in Early Development for Cancer Therapy.

Molecular glue degraders are an emerging class of small molecule allosteric modulators that induce or stabilize protein-protein interactions, enabling targeted degradation of previously intractable proteins. By redirecting E3 ligases to recognize neosubstrates, proteins that are not typically recognized by a specific E...

E. Ozdemir, H. Jang, Ozlem Keskin et al. · 0 citations
Open access Jul 2026

How Functional Variants Reconfigure the Rac2 Conformational Landscape

Using molecular dynamics simulations, this work provides a high-resolution, mechanistic framework for understanding how localized perturbations in the switch loops landscape dictate systemic cellular outcomes.

Nurit Haspel, H. Jang, R. Nussinov · 0 citations
Open access Aug 2026

Single-Cell Mapping of Malignant Signaling Networks Guides Drug Combinations

Findings support rational drug combinations targeting HIF-1 together with upstream PI3K/AKT/mTOR, MAPK, MAPK, or JAK/STAT signaling in single-cell breast cancer atlases.

B. R. Yavuz, H. Jang, R. Nussinov · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.